CD8A and hyperplastic polyp: Current therapeutics fail to inhibit these cytotoxic, pro-inflammatory molecules known to be associated with the disease process in COPD and our findings of a non-significant decrease in these molecules in CD8 + T and CD8 + NKT-like cells in the presence of MP confirm these clinical findings.